Protara Therapeutics, Inc.

Biotechnology

About Protara Therapeutics, Inc.

Protara Therapeutics is a clinical-stage biotechnology company developing transformative therapies for people with cancer and rare diseases. The company's lead candidate, TARA-002, is an investigational cell-based therapy in development for non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs), with ongoing Phase 2 trials in both indications. Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral support. The company has been recognized as one of the Best Places to Work by BioSpace, reflecting its commitment to culture, career growth, and innovation.

Work at Protara Therapeutics, Inc.?

Post a role here — reach candidates already searching for your company.

Open Positions at Protara Therapeutics, Inc. (1)

Director, Data Management

Protara Therapeutics, Inc.

Full-time

RemoteUSD 225,000 - 230,0002 months ago

Hiring Intelligence

Beta · Sourced from candidate reports

Be the first to share your experience with Protara Therapeutics, Inc..

Your reply helps other candidates know what to expect.